XML 59 R44.htm IDEA: XBRL DOCUMENT v3.24.3
Stockholders' Equity - Schedule of Stockholders' Equity (Details) - USD ($)
shares in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2024
Sep. 30, 2023
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Balance of shares outstanding, beginning of period (in shares)     157,586       157,586  
Balance, beginning of period $ 915,809,000 $ 931,210,000 $ 947,740,000 $ 971,204,000 $ 820,932,000 $ 774,357,000 $ 947,740,000 $ 774,357,000
Non-cash share-based compensation 2,781,000 2,887,000 1,409,000 1,794,000 1,976,000 1,124,000    
Purchase and retirement of common stock (28,578,000) (39,203,000) (33,222,000)   0      
Exercise of stock options and vesting of restricted stock units, net of shares withheld to satisfy tax withholding 80,000 91,000 (773,000) 1,032,000 44,000 (447,000)    
Equitable adjustments to stock-based awards (3,000) 19,000 21,000   24,000 (13,000)    
Change in noncontrolling interests       2,000   (124,000)    
Net income (loss) 85,327,000 128,351,000 (10,848,000) 35,981,000 56,313,000 (26,762,000) 202,830,000 65,532,000
Foreign currency translation adjustment, net of tax of $0 $ (80,091,000) (107,546,000) 26,883,000 (46,371,000) 91,915,000 72,797,000 $ (160,754,000) 118,341,000
Balance of shares outstanding, end of period (in shares) 150,685           150,685  
Balance, end of period $ 895,325,000 915,809,000 931,210,000 963,642,000 971,204,000 820,932,000 $ 895,325,000 963,642,000
Foreign currency translation adjustment, tax $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0
Common stock                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Balance of shares outstanding, beginning of period (in shares) 152,546 155,160 157,586 157,220 157,174 157,013 157,586 157,013
Balance, beginning of period $ 610,000 $ 621,000 $ 630,000 $ 629,000 $ 924,000 $ 923,000 $ 630,000 $ 923,000
Purchase and retirement of common stock (in shares) (1,895) (2,661) (2,607)          
Purchase and retirement of common stock $ (7,000) $ (11,000) $ (10,000)   $ (295,000)      
Exercise of stock options and vesting of restricted stock units, net of shares withheld to satisfy tax withholding (in shares) 34 47 181 147 46 161    
Exercise of stock options and vesting of restricted stock units, net of shares withheld to satisfy tax withholding     $ 1,000   $ 0 $ 1,000    
Balance of shares outstanding, end of period (in shares) 150,685 152,546 155,160 157,367 157,220 157,174 150,685 157,367
Balance, end of period $ 603,000 $ 610,000 $ 621,000 $ 629,000 $ 629,000 $ 924,000 $ 603,000 $ 629,000
Additional paid-in capital                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Balance, beginning of period 1,142,081,000 1,160,865,000 1,179,721,000 1,181,501,000 2,205,434,000 2,204,755,000 1,179,721,000 2,204,755,000
Non-cash share-based compensation 2,781,000 2,887,000 1,409,000 1,794,000 1,976,000 1,124,000    
Purchase and retirement of common stock (14,190,000) (21,781,000) (19,512,000)   (1,025,977,000)      
Exercise of stock options and vesting of restricted stock units, net of shares withheld to satisfy tax withholding 80,000 91,000 (774,000) 1,032,000 44,000 (448,000)    
Equitable adjustments to stock-based awards (3,000) 19,000 21,000   24,000 (13,000)    
Change in noncontrolling interests       2,000   16,000    
Balance, end of period 1,130,749,000 1,142,081,000 1,160,865,000 1,184,329,000 1,181,501,000 2,205,434,000 1,130,749,000 1,184,329,000
Retained earnings                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Balance, beginning of period 128,130,000 17,411,000 41,862,000 68,814,000 12,637,000 39,244,000 41,862,000 39,244,000
Purchase and retirement of common stock (14,381,000) (17,411,000) (13,700,000)          
Net income (loss) 85,463,000 128,130,000 (10,751,000) 36,158,000 56,177,000 (26,607,000)    
Balance, end of period 199,212,000 128,130,000 17,411,000 104,972,000 68,814,000 12,637,000 199,212,000 104,972,000
Accumulated other comprehensive loss                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Balance, beginning of period (352,807,000) (245,261,000) (272,144,000) (277,626,000) (369,633,000) (442,424,000) (272,144,000) (442,424,000)
Foreign currency translation adjustment, net of tax of $0 (80,091,000) (107,546,000) 26,883,000 (46,373,000) 92,007,000 72,791,000    
Balance, end of period (432,898,000) (352,807,000) (245,261,000) (323,999,000) (277,626,000) (369,633,000) (432,898,000) (323,999,000)
Treasury stock at cost                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Balance, beginning of period       0 (1,026,272,000) (1,026,272,000)   (1,026,272,000)
Purchase and retirement of common stock         1,026,272,000      
Balance, end of period       0 0 (1,026,272,000)   0
Non-controlling interests                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Balance, beginning of period (2,205,000) (2,426,000) (2,329,000) (2,114,000) (2,158,000) (1,869,000) (2,329,000) (1,869,000)
Change in noncontrolling interests           (140,000)    
Net income (loss) (136,000) 221,000 (97,000) (177,000) 136,000 (155,000)    
Foreign currency translation adjustment, net of tax of $0 0 0 0 2,000 (92,000) 6,000    
Balance, end of period $ (2,341,000) $ (2,205,000) $ (2,426,000) $ (2,289,000) $ (2,114,000) $ (2,158,000) $ (2,341,000) $ (2,289,000)